Loading candles…
Indo Amines Limited, incorporated in 1992, is a global manufacturer and supplier of fine and specialty chemicals, with a focus on fatty amines and their derivatives. The company operates in industries including pharmaceuticals, agrochemicals, fertilizers, water treatment, and fine and specialty chemicals. It serves a diverse range of sectors by providing chemical intermediates produced through indigenous manufacturing technology. One of the company's key objectives is to reduce import dependency for critical chemical intermediates. No specific information on founders, key management, subsidiaries, project involvement, geographic presence, or stock exchange listings is available.
This page is a live market overview for INDO AMINES LIMITED (INDOAMIN) on the NSE. As a listed security, INDO AMINES LIMITED is tracked in the Chemicals segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for INDOAMIN before placing trades on tick2trade.
As of the latest feed, INDOAMIN last traded at ₹137.5 on NSE, up ₹2.7 (2.00%) from the previous close of ₹134.8. Today's session range is ₹134.1 – ₹139, against a 52-week band of ₹81.9 – ₹149. Traded volume today stands at 69.25K shares.
The overview consolidates an interactive price chart with multiple time ranges, five-level bid and ask depth, recent market headlines, upcoming corporate events for INDOAMIN in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether INDOAMIN is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for INDO AMINES LIMITED before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in INDOAMIN. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated INDOAMIN option chain page linked from this overview.
| Type | Details | Date |
|---|---|---|
| Unaudited Results - Q1-FY26 | To consider and approve the Un-Audited Financial Results (Standalone and Consolidated) of the Company for the quarter ended 30th June, 2026. | 12 Aug 2026 |
| Results - FY26 | To consider and approve the financial results for the period ended March 31, 2026 and dividend | 26 May 2026 |
| Results - FY25 | To consider and approve the financial results for the period ended December 31, 2025 | 7 Feb 2026 |
| Results - FY25 | To consider and approve the financial results for the period ended September 30, 2025 | 12 Nov 2025 |
| Unaudited Results - FY25 | To consider and approve the unaudited financial results for the period ended Jun 30, 2025 | 12 Aug 2025 |
| Results - FY25 | To consider and approve the financial results for the period ended March 31, 2025 and dividend | 22 May 2025 |
Tick2trade is a brand/platform owned and operated by Besseggen InfoTech LLP, a SEBI Registered Stock Broker holding Registration No: INZ000213450, Member of NSE (Member Code: 90155) and BSE (Member Code: 6722). Investment in securities market are subject to market risks; read all related documents carefully before investing.